57955-6031 NDC - SCIATIC NERVE FORMULA (AESCULUS HIPPOCASTANUM, AMMONIUM MURIATICUM, ARSENICUM ALBUM, BELLADONNA, CAPSICUM ANNUUM, CAUSTICUM, COLCHICUM AUTUMNALE, COLOCYNTHIS, GNAPHALIUM POLYCEPHALUM, IGNATIA AMARA, HYPERICUM PERFORATUM, MAGNESIA PHOSPHORICA, RHUS TOX, RUTA GRAVEOLENS)

Drug Information

Product NDC: 57955-6031

Proprietary Name: Sciatic Nerve Formula

Non Proprietary Name: Aesculus hippocastanum, Ammonium muriaticum, Arsenicum album, Belladonna, Capsicum annuum, Causticum, Colchicum autumnale, Colocynthis, Gnaphalium polycephalum, Ignatia amara, Hypericum perforatum, Magnesia phosphorica, Rhus tox, Ruta graveolens

Active Ingredient(s):
  • 10 [hp_X]/59mL AMMONIUM CHLORIDE;
  • 10 [hp_X]/59mL ARSENIC TRIOXIDE;
  • 10 [hp_X]/59mL ATROPA BELLADONNA;
  • 10 [hp_X]/59mL CAPSICUM;
  • 10 [hp_X]/59mL CAUSTICUM;
  • 10 [hp_X]/59mL CITRULLUS COLOCYNTHIS FRUIT PULP;
  • 10 [hp_X]/59mL COLCHICUM AUTUMNALE BULB;
  • 10 [hp_X]/59mL HORSE CHESTNUT;
  • 10 [hp_X]/59mL HYPERICUM PERFORATUM WHOLE;
  • 10 [hp_X]/59mL KALMIA LATIFOLIA LEAF;
  • 10 [hp_X]/59mL MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE;
  • 10 [hp_X]/59mL PSEUDOGNAPHALIUM OBTUSIFOLIUM WHOLE;
  • 10 [hp_X]/59mL RUTA GRAVEOLENS FLOWERING TOP;
  • 10 [hp_X]/59mL STRYCHNOS IGNATII SEED;
  • 10 [hp_X]/59mL TOXICODENDRON PUBESCENS LEAF


Administration Route(s): ORAL

Dosage Form(s): LIQUID

Pharmacy Class(es):
  • Allergens [CS];
  • Calculi Dissolution Agent [EPC];
  • Cell-mediated Immunity [PE];
  • Dietary Proteins [CS];
  • Increased Histamine Release [PE];
  • Increased Large Intestinal Motility [PE];
  • Inhibition Large Intestine Fluid/Electrolyte Absorption [PE];
  • Inhibition Small Intestine Fluid/Electrolyte Absorption [PE];
  • Magnesium Ion Exchange Activity [MoA];
  • Non-Standardized Food Allergenic Extract [EPC];
  • Non-Standardized Plant Allergenic Extract [EPC];
  • Osmotic Activity [MoA];
  • Osmotic Laxative [EPC];
  • Plant Proteins [CS];
  • Stimulation Large Intestine Fluid/Electrolyte Secretion [PE];
  • Vegetable Proteins [CS]

Labeler Information

Labeler Name: King Bio Inc.
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date:10/19/2022

Package Information

No. Package Code Package Description Billing Unit
157955-6031-21 BOTTLE, SPRAY in 1 CARTON (57955-6031-2) / 59 mL in 1 BOTTLE, SPRAY

NDC Record

Field Name Field Value Definition
PRODUCT NDC57955-6031The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMESciatic Nerve FormulaThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMEAesculus hippocastanum, Ammonium muriaticum, Arsenicum album, Belladonna, Capsicum annuum, Causticum, Colchicum autumnale, Colocynthis, Gnaphalium polycephalum, Ignatia amara, Hypericum perforatum, Magnesia phosphorica, Rhus tox, Ruta graveolensThe non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMELIQUIDThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE10/19/2022This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEKing Bio Inc.Name of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEAMMONIUM CHLORIDE; ARSENIC TRIOXIDE; ATROPA BELLADONNA; CAPSICUM; CAUSTICUM; CITRULLUS COLOCYNTHIS FRUIT PULP; COLCHICUM AUTUMNALE BULB; HORSE CHESTNUT; HYPERICUM PERFORATUM WHOLE; KALMIA LATIFOLIA LEAF; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; PSEUDOGNAPHALIUM OBTUSIFOLIUM WHOLE; RUTA GRAVEOLENS FLOWERING TOP; STRYCHNOS IGNATII SEED; TOXICODENDRON PUBESCENS LEAFAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10; 10 
ACTIVE INGRED UNIT[hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL; [hp_X]/59mL 
PHARM CLASSESAllergens [CS], Calculi Dissolution Agent [EPC], Cell-mediated Immunity [PE], Dietary Proteins [CS], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Laxative [EPC], Plant Proteins [CS], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vegetable Proteins [CS] 

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 5/26/2023